These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9224984)

  • 21. Effect of increased hemodialysis dose on endogenous erythropoietin production in end-stage renal disease.
    Ifudu O; Friedman EA
    Nephron; 1998; 79(1):50-4. PubMed ID: 9609462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current management of anemia in adult hemodialysis patients with end-stage renal disease.
    Frankenfield DL; Johnson CA
    Am J Health Syst Pharm; 2002 Mar; 59(5):429-35. PubMed ID: 11887409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnosis of renal carcinoma in acquired cystic renal disease. Usefulness of echography in detection during subclinical phase].
    Ayuso JR; Almirall J; Ayuso C; Bru C; Ponz E; Revert L
    Med Clin (Barc); 1991 Apr; 96(16):607-10. PubMed ID: 2051828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of recombinant human erythropoietin in the correction of anemia in predialysis patients and its effect on renal function: a double-blind, placebo-controlled trial.
    Kleinman KS; Schweitzer SU; Perdue ST; Bleifer KH; Abels RI
    Am J Kidney Dis; 1989 Dec; 14(6):486-95. PubMed ID: 2688405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant human erythropoietin independence in chronic hemodialysis patients: clinical features, iron homeostasis and erythropoiesis.
    Kuo CC; Lee CT; Chuang CH; Su Y; Chen JB
    Clin Nephrol; 2005 Feb; 63(2):92-7. PubMed ID: 15730050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. End stage renal disease associated with acquired cystic disease and neoplasia.
    Basile JJ; McCullough DL; Harrison LH; Dyer RB
    J Urol; 1988 Nov; 140(5):938-43. PubMed ID: 3172362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dialysis-associated renal cystic disease resembling autosomal dominant polycystic kidney disease: a report of two cases.
    Bakir AA; Hasnain M; Young S; Dunea G
    Am J Nephrol; 1999; 19(4):519-22. PubMed ID: 10460946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical efficacy of recombinant human erythropoietin in the treatment of anemia in hemodialysis patients: influence of dosing regimen, iron status, and serum aluminum.
    Tsai JC; Lai YH; Tsai ZY; Chien LJ; Tsai JH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Mar; 7(3):126-35. PubMed ID: 1865507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acquired renal cystic disease in the end stage kidney: urological implications.
    Brendler CB; Albertsen PC; Goldman SM; Hill GS; Lowe FC; Millan JC
    J Urol; 1984 Sep; 132(3):548-52. PubMed ID: 6471194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of the treatment with human recombinant erythropoietin on anemia in children with end-stage kidney failure. French multicenter study].
    Sinnassamy P; Andre JL; Treize G; Leroy B
    Arch Fr Pediatr; 1993 Mar; 50(3):201-8. PubMed ID: 8338412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acquired cystic kidney disease before and after renal transplantation.
    Querfeld U; Schneble F; Wradzidlo W; Waldherr R; Tröger J; Schärer K
    J Pediatr; 1992 Jul; 121(1):61-4. PubMed ID: 1625094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma erythropoietin levels and acquired cystic disease of the kidney in patients receiving regular haemodialysis treatment.
    Edmunds ME; Devoy M; Tomson CR; Krishna U; Clayworth A; Durrant ST; Feehally J; Walls J
    Br J Haematol; 1991 Jun; 78(2):275-7. PubMed ID: 2064967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cost-effectiveness analysis of anemia screening before erythropoietin in patients with end-stage renal disease.
    Hutchinson FN; Jones WJ
    Am J Kidney Dis; 1997 May; 29(5):651-7. PubMed ID: 9159297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of nutritional status of patients on haemodialysis.
    Anees M; Ahmed AM; Rizwan SM
    J Coll Physicians Surg Pak; 2004 Nov; 14(11):665-9. PubMed ID: 15530275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin.
    Wingard RL; Parker RA; Ismail N; Hakim RM
    Am J Kidney Dis; 1995 Mar; 25(3):433-9. PubMed ID: 7872321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epoetin requirement does not depend on dialysis dose when Kt/N > 1.33 in patients on regular dialysis treatment with cellulosic membranes and adequate iron stores.
    Movilli E; Cancarini GC; Vizzardi V; Camerini C; Brunori G; Cassamali S; Maiorca R
    J Nephrol; 2003; 16(4):546-51. PubMed ID: 14696757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B; Grujić-Adanja G
    Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel approach to adenine-induced chronic kidney disease associated anemia in rodents.
    Rahman A; Yamazaki D; Sufiun A; Kitada K; Hitomi H; Nakano D; Nishiyama A
    PLoS One; 2018; 13(2):e0192531. PubMed ID: 29415057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acquired cystic kidney disease: an under-recognized condition in children with end-stage renal disease.
    Chan EYH; Warady BA
    Pediatr Nephrol; 2018 Jan; 33(1):41-51. PubMed ID: 28444445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquired renal cystic disease mimicking adult polycystic kidney disease in a patient undergoing long-term hemodialysis.
    Kessler M; Testevuide P; Aymard B; Huu TC
    Am J Nephrol; 1991; 11(6):513-7. PubMed ID: 1819219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.